Candace S Johnson Selected Research

Calcitriol (Calcijex)

1/2016	Vitamin D Signaling Modulators in Cancer Therapy.
9/2015	Impact of Short-term 1,25-Dihydroxyvitamin D3 on the Chemopreventive Efficacy of Erlotinib against Oral Cancer.
1/2014	Early growth inhibition is followed by increased metastatic disease with vitamin D (calcitriol) treatment in the TRAMP model of prostate cancer.
7/2013	24-Hydroxylase in cancer: impact on vitamin D-based anticancer therapeutics.
2/2012	The role of vitamin D in cancer prevention and treatment.
10/2011	Dexamethasone enhances 1alpha,25-dihydroxyvitamin D3 effects by increasing vitamin D receptor transcription.
1/2011	Oral bioavailability of DN101, a concentrated formulation of calcitriol, in tumor-bearing dogs.
9/2010	CYP24A1 inhibition enhances the antitumor activity of calcitriol.
8/2010	Calcitriol enhances gemcitabine anti-tumor activity in vitro and in vivo by promoting apoptosis in a human pancreatic carcinoma model system.
7/2010	Vitamin D in combination cancer treatment.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Candace S Johnson Research Topics

Disease

69	Neoplasms (Cancer) 01/2021 - 01/2002
31	Prostatic Neoplasms (Prostate Cancer) 01/2019 - 01/2002
19	Hypercalcemia (Milk Alkali Syndrome) 01/2016 - 01/2002
12	Squamous Cell Carcinoma (Epidermoid Carcinoma) 10/2015 - 07/2002
7	Breast Neoplasms (Breast Cancer) 01/2021 - 02/2011
7	Urinary Bladder Neoplasms (Bladder Cancer) 01/2019 - 07/2010
7	Neoplasm Metastasis (Metastasis) 09/2017 - 05/2006
4	Vitamin D Deficiency 01/2019 - 02/2009
4	Leukemia 02/2014 - 05/2004
3	Inflammation (Inflammations) 01/2016 - 06/2010
3	Lung Neoplasms (Lung Cancer) 05/2008 - 05/2004
2	7 Hereditary Prostate Cancer 01/2019 - 01/2018
2	Adenocarcinoma 01/2014 - 03/2007
2	Colorectal Neoplasms (Colorectal Cancer) 08/2013 - 02/2009
2	Wounds and Injuries (Trauma) 10/2010 - 09/2009
2	Pancreatic Neoplasms (Pancreatic Cancer) 08/2010 - 01/2010
2	Lymphoma (Lymphomas) 07/2006 - 05/2004
1	Adenocarcinoma of Lung 03/2020
1	Residual Neoplasm 01/2019
1	Chronic Disease (Chronic Diseases) 01/2018
1	Granular Cell Tumor 10/2015
1	Squamous Cell Carcinoma of Head and Neck 09/2015
1	Mouth Neoplasms (Oral Cancer) 09/2015
1	Carcinogenesis 09/2015
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 02/2014
1	Carcinoma (Carcinomatosis) 02/2014
1	Chromothripsis 02/2014

Drug/Important Bio-Agent (IBA)

43	Vitamin D FDA LinkGeneric 01/2021 - 01/2002
41	Calcitriol (Calcijex)FDA LinkGeneric 01/2016 - 01/2002
12	Dexamethasone (Maxidex)FDA LinkGeneric 01/2016 - 01/2002
11	AndrogensIBA 01/2014 - 01/2002
10	Cholecalciferol (Vitamin D3)FDA Link 03/2020 - 01/2006
9	hydroxide ionIBA 01/2019 - 01/2010
7	Cisplatin (Platino)FDA LinkGeneric 01/2019 - 08/2002
7	GlucocorticoidsIBA 10/2011 - 01/2002
6	Calcitriol Receptors (Calcitriol Receptor)IBA 09/2017 - 09/2002
6	Proteins (Proteins, Gene)FDA Link 01/2016 - 10/2003
6	Vitamin D3 24-HydroxylaseIBA 01/2016 - 07/2010
5	Estrogen ReceptorsIBA 01/2021 - 02/2011
5	CalciumIBA 01/2018 - 07/2006
5	EnzymesIBA 01/2016 - 07/2006
5	25-hydroxyvitamin DIBA 01/2015 - 02/2011
5	Carboplatin (JM8)FDA LinkGeneric 07/2010 - 01/2002
4	1,25-dihydroxyvitamin DIBA 01/2019 - 07/2002
4	MicroRNAs (MicroRNA)IBA 04/2015 - 01/2014
4	Pharmaceutical PreparationsIBA 02/2012 - 01/2002
4	Docetaxel (Taxotere)FDA Link 07/2010 - 05/2004
4	Paclitaxel (Taxol)FDA LinkGeneric 07/2010 - 01/2002
3	Biomarkers (Surrogate Marker)IBA 01/2021 - 07/2014
3	LigandsIBA 01/2016 - 07/2006
3	Prostate-Specific Antigen (Semenogelase)IBA 01/2015 - 08/2002
3	DNA (Deoxyribonucleic Acid)IBA 02/2014 - 07/2010
3	Hormones (Hormone)IBA 01/2014 - 08/2004
3	Gemcitabine FDA Link 08/2010 - 07/2010
3	matrigelIBA 07/2010 - 09/2006
3	Taxoids (Taxanes)IBA 07/2006 - 01/2004
2	Biological ProductsIBA 01/2019 - 09/2013
2	protein C activator peptideIBA 01/2018 - 01/2015
2	CarcinogensIBA 09/2015 - 05/2004
2	Cadherins (E-Cadherin)IBA 01/2014 - 02/2013
2	Antineoplastic Agents (Antineoplastics)IBA 01/2011 - 06/2010
2	SteroidsIBA 09/2010 - 07/2010
2	Cytidine DeaminaseIBA 08/2010 - 01/2007
2	MineralsIBA 07/2010 - 07/2006
2	Gefitinib (Iressa)FDA Link 12/2009 - 02/2007
2	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 08/2006 - 07/2004
2	VA 061 (VA061)IBA 07/2006 - 05/2004
2	2,3,4-tri-O-acetylarabinopyranosyl isothiocyanate (AITC)IBA 10/2003 - 05/2003
2	allyl isothiocyanateIBA 10/2003 - 05/2003
1	Tyrosine Kinase InhibitorsIBA 03/2020
1	MagnesiumIBA 01/2018
1	ORALIT (ORS)IBA 01/2018
1	AmberIBA 05/2016
1	N-nitroso-tris-chloroethylureaIBA 10/2015
1	pazopanib FDA Link 10/2015
1	ErbB Receptors (EGF Receptor)IBA 09/2015
1	Erlotinib Hydrochloride (CP 358,774)FDA Link 09/2015
1	4-Nitroquinoline-1-oxide (4 Nitroquinoline 1 oxide)IBA 09/2015
1	Calcifediol (Calcidiol)FDA Link 01/2015
1	Ionotropic Glutamate ReceptorsIBA 02/2014
1	NucleotidesIBA 02/2014
1	CytokinesIBA 01/2014
1	Interleukin-5 (Interleukin 5)IBA 01/2014
1	QW 1624F2-1IBA 01/2014
1	Differentiation AntigensIBA 01/2014
1	Cell Adhesion MoleculesIBA 09/2013
1	von Willebrand FactorIBA 09/2013
1	Vascular Endothelial Growth Factor Receptor-1 (fms-Like Tyrosine Kinase)IBA 09/2013
1	Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA 09/2013
1	A-factor (Streptomyces)IBA 07/2013
1	Oxygen (Dioxygen)IBA 06/2013
1	Angiogenesis InhibitorsIBA 06/2013
1	Casein Kinase II (Casein Kinase 2)IBA 04/2013

Therapy/Procedure

18	Therapeutics 01/2021 - 01/2002
3	Prostatectomy (Retropubic Prostatectomy) 02/2014 - 05/2009
3	Drug Therapy (Chemotherapy) 07/2010 - 02/2009
2	Castration 01/2014 - 01/2010
1	Cystectomy 01/2019
1	Segmental Mastectomy (Lumpectomy) 10/2016
1	Chemoprevention 09/2015